Yalpi foyda bo'yicha rentabellik: 4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Inc (FDMT) brendining ramzi va logotipi

Joriy yalpi foyda marjasi darajasi global CMOlar bilan tuzilgan, ishlab chiqarish risklarini minimallashtiruvchi qat'iy SLA shartnomalarining ta'sirini aks ettiradi. Shu bilan birga, 4D Molecular Therapeutics (FDMT) vektorlarni yaratish va sinovdan o'tkazishda tashqi hamkorlarga tayanadi, biomateriallarni tashish uchun esa qat'iy harorat nazoratini joriy qiladi. Ushbu grafikdagi tendentsiya moliyaviy barqarorlikni tasdiqlaydi, bunda 91.50 darajasi 4D Molecular Therapeutics (FDMT) kompaniyasining joriy daromadliligini ko'rsatadi.

4D Molecular Therapeutics (FDMT) Yalpi foyda normasi: 04.07.2022 - 20.11.2026 davri uchun

4D Molecular Corp (FDMT) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
4D Molecular Therapeutics Inc tayyor mahsulotlari

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlaridan keyin qolgan daromad qismini belgilaydi, bu esa investorlarga operatsion modelning ichki samaradorligini baholash imkonini beradi. Yuqori texnologiyali gen terapiyasi va qat'iy klinik intizomga e'tibor qaratgan 4D Molecular Therapeutics (FDMT) uchun yalpi foyda marjasi koeffitsiyenti innovatsion dori vositalarini hujayralarga yetkazib berish usullarini ishlab chiqish xarajatlarini optimallashtirish bo'yicha rahbariyatning qobiliyatini aks ettiradi.

4D Molecular Therapeutics raqobatchilari

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik